Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
Author:
- 1 December 1996
- journal article
- review article
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 15 (4) , 267-276
Abstract
This article reviews the adverse cutaneous reactions to antineoplastic chemotherapeutic agents and cytokine therapy. The article details specific reactions such as acral erythemas and flushing reactions. It also discusses nonspecific reactions with specific histological features such as neutrophilic eccrine hidradenitis and syringosquamous metaplasia. The wide variety of cutaneous reactions to cytokine therapy such as from recombinant interleukins and the colony stimulating factors are reviewed.Keywords
This publication has 58 references indexed in Scilit:
- Dapsone in prevention of recurrent neutrophilic eccrine hidradenitisJournal of the American Academy of Dermatology, 1996
- Hydroxyurea-induced nail pigmentationJournal of the American Academy of Dermatology, 1996
- A randomized trial of minoxidil in chemotherapy-induced alopeciaJournal of the American Academy of Dermatology, 1996
- Interleukin-3—induced urticaria-like eruptionJournal of the American Academy of Dermatology, 1996
- Cutaneous reactions to recombinant cytokine therapyJournal of the American Academy of Dermatology, 1995
- Cutaneous side effects associated with interleukin 2 administration for metastatic melanomaJournal of the American Academy of Dermatology, 1993
- Systemic lupus erythematosus in a child receiving long-term interferon therapyThe Journal of Pediatrics, 1992
- Therapeutic use of cytokines in dermatologyJournal of the American Academy of Dermatology, 1991
- Mitoxantrone-induced discoloration of the nailsEuropean Journal of Cancer and Clinical Oncology, 1989
- Interferon alfa-2a in the treatment of cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989